Leadership - An international, multi-sector Steering Team:
Dr. Marilyn Aardema Dr. David Jacobson-Kram
The Proctor and Gamble Company, U.S. U.S. Food and Drug Administration
Dr. Daniel Casciano (Scientific Advisor) Dr. Peter Kasper
(formerly) Nat’l Center for Tox. Research BfArM, Germany
Dr. Vicki Dellarco Dr. James MacGregor (Scientific Advisor)
U.S. Environmental Protection Agency Toxicology Consulting Services, U.S.
Dr. B. Bhaskar Gollapudi (Vice Chair) Dr. Robert Rees
The Dow Chemical Company, U.S. GlaxoSmithKline, U.K.
Dr. Makato Hayashi Dr. Veronique Thybaud (Chair)
Nat’l Institute of Health Sciences, Japan sanofi-aventis, France
Dr. Michael Holsapple (HESI Staff)
ILSI Health and Environ. Sciences Inst., U.S.
Membership – Representatives from the HESI Assembly:
3M Pharmaceuticals, Abbott Laboratories, Amgen, Inc., AstraZeneca, BASF Corporation, Bayer CropScience, Bayer HealthCare AG, Berlex Laboratories, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharma GmbH, Bristol-Myers Squibb, The Dow Chemical Company, Eli Lilly and Company, GlaxoSmithKline, Hoffman-La Roche, Johnson & Johnson, L’Oreal, Merck Research Laboratories, Novartis Pharma AG, Pfizer Inc, The Procter & Gamble Company, sanofi-aventis, Schering-Plough Research Institute,SERVIER Group, Tanabe Seiyaku Co., Ltd.
Public Participation – Representatives from government, academia and industry:
Alfred I. DuPont Hospital for Children, BfArM (Germany), Covance Laboratories, European Food Safety Authority, Huntington Life Sciences, Lexicon Genetics, Michigan State University, National Center for Toxicological Research (U.S.), National Institute of Health Sciences (Japan), RIVM (The Netherlands), Toxicology Consulting Services, U.S. Department of Agriculture, U.S. Environmental Protection Agency, U.S. Food and Drug Administration
Activities – Past activities in 2006:
· The IVGT sponsored a 2-day international workshop of the full membership in June of 2006. The goal of the workshop was to further identify approaches to be taken by the Subcommittee to address the Mission, and to fulfill the Objectives. To access materials from the workshop, click here.
· Members of the Subcommittee Steering Team met in February, 2006, to develop a consensus for the mission, specific objectives and initial approaches.
· The Subcommittee Steering Team submitted an abstract for the Annual Meeting of the Japanese Society of Toxicology in Nagoya in July, 2006, as part of its outreach strategy.